Sensus Healthcare SRT-100 Vision™ Informational Video
Law360, New York (March 30, 2016, 3:38 PM EDT) -- Sensus Healthcare, a Florida-based medical device company that sells X-ray systems treating nonmelanoma skin cancer, postponed a $20 million initial public offering, according to Wednesday reports, marking the latest setback in a jittery IPO market.
Boca Raton, Florida-based Sensus Healthcare Inc. earlier this month told regulators it planned to issue 1.8 million shares priced between $10 and $12, which was the lone IPO scheduled to price this week.
Researcher Renaissance Capital's report did not indicate a reason for the delay, though numerous companies have postponed or canceled plans in early 2016 amid weak market conditions.
Messages to Sensus were not immediately returned...
Stay ahead of the curve
In the legal profession, information is the key to success.
You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
- Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
- Create custom alerts for specific article and case topics and so much more!
TRY LAW360 FREE FOR SEVEN DAYS